Atlas Trials

An Efficacy Study Of Ortataxel In Recurrent Glioblastoma

Clinical trial NCT01989884 · COMPLETED

Trial details

NCT number
NCT01989884
Sponsor
Mario Negri Institute for Pharmacological Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2013-11-01
Primary completion
2015-12-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.